98P Intermittent first-line anti-EGFR with chemotherapy improves the survival of patients with RAS and BRAF wild type metastatic colon cancer
Kumar, S., Dewdney, A., Crossley, R., Wilshaw, V., Joyce, H., Koshy, E., Al-Khaldi, A., Khaira, M.
Published in Annals of oncology (01.06.2024)
Published in Annals of oncology (01.06.2024)
Get full text
Journal Article